Efficacy of Curcumin as Adjuvant Therapy to Induce or Maintain Remission in Ulcerative Colitis Patients: an Evidence-based Clinical Review
Background: treatment guidelines for ulcerative colitis (UC) not yet established. Currently, mesalazine, corticosteroids, and immunomodulators are treatment options for UC. However, they are known to have unpleaseant side effects such as nausea, vomiting, headaches, hepatitis, and male infertility....
Saved in:
Main Authors: | Marcellus Simadibrata (Author), Christopher Christian Halimkesuma (Author), Benedicta Mutiara Suwita (Author) |
---|---|
Format: | Book |
Published: |
Interna Publishing,
2018-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Maintaining remission in ulcerative colitis – role of once daily extended-release mesalamine
by: Lilliana Oliveira, et al.
Published: (2011) -
Curcumin as adjuvant therapy to improve remission in myeloma patients: A pilot randomized clinical trial
by: Damai Santosa, et al.
Published: (2022) -
Use of corticosteroids for remission induction therapy in patients with new-onset ulcerative colitis in real-world settings
by: Motohiro Okayasu, et al.
Published: (2019) -
Evaluation of false remission in ulcerative colitis and the need for a revised disease activity index
by: Alaa Elgamal, et al.
Published: (2014) -
Oral colon-targeting core-shell microparticles loading curcumin for enhanced ulcerative colitis alleviating efficacy
by: Chen Zhang, et al.
Published: (2021)